Of the four paired case–control studies included herein, three studies revealed that ALPK1 is strongly associated with cancer progression and metastasis, whereas one study demonstrated that ALPK1 is a driver of low- and high-grade spiradenocarcinoma. This evidence concerns the gene ALPK1 and cancer.